Sales & Marketing Views & Analysis

Views & Analysis

Sales & Marketing

The exponential imperative: Rethinking biopharma strategy fo...

The biopharma industry – long a powerhouse of scientific innovation – now stands at a critical inflection point.

Sales & Marketing

KOL data for HCP engagement representation

Bad KOL data is expensive: Harnessing high-quality data for ...

As biopharmas increasingly rely on AI and advanced data-driven technologies, evaluating the quality of data is critical.

Sales & Marketing

Changing Faces: Board appointments in March 2025

One area in which March proved to be a busy month was in Board appointments, where both Boards of Directors and Advisory Boards saw a number of interesting additions.

Sales & Marketing

Executing established pharma brand strategy: Key considerati...

As blockbuster drug patents edge closer to expiry, pharma companies must rethink how they invest in, support, and scale established brands

Sales & Marketing

Solution Spotlight: iON.AI

iON.AI is a powerful, compliance-driven platform purpose-built for Medical Affairs, seamlessly blending human expertise with AI.

Sales & Marketing

illustrative concept for searching solutions, brainstorming and planning strategy

Harnessing zero‑party data: Transforming pharma advertising ...

Integrating zero-party data into ads, pharma and healthcare brands can revolutionise how they engage with patients

The exponential imperative: Rethinking biopharma strategy fo...

Bad KOL data is expensive: Harnessing high-quality data for ...

Changing Faces: Board appointments in March 2025

Executing established pharma brand strategy: Key considerati...

Solution Spotlight: iON.AI

Harnessing zero‑party data: Transforming pharma advertising ...

US puts $125m into personalised RNA therapy production

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks